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Abstract  
Rotavirus A strains detected from diarrhoeal children commonly possess any one of the 
genotypes G1, G2, G3, G4, and G9, with a recent increase in G12 detection globally. 
G12P[6] strains possessing short RNA (DS-1-like) and long RNA (Wa-like) migration 
patterns accounted for 27% of the strains circulating in Blantyre, Malawi between 2007 
and 2008. To understand how the G12P[6] strains with two distinct genetic backgrounds 
emerged in Malawi, we conducted whole genome analysis of two long RNA and two 
short RNA strains. While the former had a typical Wa-like genotype constellation of 
G12-P[6]-I1-R1-C1-M1-A1-N1-T1-E1-H1, the latter was found to have 
G12-P[6]-I2-R2-C2-M1-A2-N2-T2-E2-H2: a VP3 gene mono-reassortant on the 
DS-1-like backbone. Phylogenetic and Bayesian Markov chain Monte Carlo analyses 
showed that the short RNA G12P[6] strains were generated around 2006 by 
reassortment between an African Wa-like G12P[6] strain donating three genes (the VP7, 
VP4, and VP3 genes) and a G2P[4] strain similar to the one circulating in Thailand or 
the United States of America that donated the remaining eight genes. On the other hand, 
the long RNA strains were generated as a result of reassortment events within Wa-like 
G12 and non-G12 strains commonly circulating in Africa; only the VP4 gene was from 
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a Malawian G8P[6] strain. In conclusion, this study uncovered the evolutionary 
pathways through which two distinct G12P[6] strains emerged in Malawi. 
 
Keywords: rotavirus; genotype constellation; reassortment; G12; P[6]; phylogenetic 
analysis; Malawi 
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Introduction 
Rotavirus A (RVA), a major cause of severe acute gastroenteritis in infants and 
young children worldwide (1), taxonomically belongs to the genus Rotavirus within the 
family Reoviridae (2). The genome of RVA consists of 11 segments of double-stranded 
RNA, coding for six structural viral proteins (VPs) and six non-structural proteins 
(NSPs); each genome segment codes for a single viral protein, with the exception of 
genome segment 11 that encodes two proteins (NSP5 and NSP6) (2). Genotypes are 
assigned according to the pre-defined nucleotide sequence identity for the open reading 
frame of each gene, and designated using a letter, which refers to a property or function 
of the protein encoded by a given gene, and a number (3). Thus, VP7 (glycoprotein) and 
VP4 (protease-sensitive protein) are referred to as G and P types, respectively. There 
have been 28 G and 39 P genotypes thus far reported for all mammalian and avian RVA 
strains in the literature (3, 4), but most human RVA strains are known to carry one of 
five G and P type combinations: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8] (5, 6). 
More recently, however, the G12 genotype in combination with P[6] or P[8] , and less 
frequently with P[4] or P[9], have been considered to constitute major human RVA 
genotype combinations as the detection of G12 strains increased (5, 7) and became 
predominant in some countries including Nepal (8-10), India (11), Spain (12), 
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Cameroon (13), Malawi (14, 15), USA (16), and Italy (17). Calculation of the 
evolutionary rate of the G12 VP7 gene estimated that the lineage containing more than 
90% of G12 VP7 genes (lineage III) disseminated globally in little more than a decade 
with the most recent common ancestor emerging around 1995 (7).  
A better understanding of the global emergence and dissemination of G12 strains 
requires information about the full genotype constellation of those strains and their 
relationships to each other as well as to other strains sharing the same genotype. In this 
regard, the recent expansion in genotype classification proposed and implemented by 
the Rotavirus Classification Working Group to include all 11 genes of RVA facilitated 
such endeavours (3, 18, 20). According to this classification system the genome of 
individual rotavirus strains is given the complete descriptor of 
Gx-P[x]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx (“x” representing the genotype number) 
denoting the VP7-VP4-VP6-VP1-VP2-VP3-NSP1-NSP2-NSP3-NSP4-NSP5 genes, 
respectively. Thus, the genotype constellations of prototype human strains Wa, DS-1 
and AU-1 are described as G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, 
G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2, and G3-P[9]-I3-R3-C3-M3-A3-N3-T3-E3- 
H3, respectively (18).  
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During a clinical trial of the attenuated human rotavirus vaccine (Rotarix®; 
GlaxoSmithKline, Biologicals, Belgium) in Blantyre, Malawi (between 2007 and 2008), 
the most prevalent genotype was G12P[6] which accounted for 27% of the rotavirus 
strains recovered from the placebo recipients (14). Upon electrophoresis, these G12P[6] 
strains showed either short RNA pattern (DS-1-like) or long RNA pattern (Wa-like), 
and RNA-RNA hybridisation revealed that the short and long RNA pattern viruses 
shared three genome segments apparently corresponding to the VP7, VP4 and VP2/VP3 
genes (19). This observation led us to hypothesise that the DS-1-like G12P[6] strains 
were generated by reassortment in which Wa-like G12P[6] strains, which are common 
globally, acquired the DS-1-like internal capsid and non-structural protein genes from 
locally circulating DS-1-like strains. To examine this hypothesis, we determined the 
complete genotype constellations of four representative G12P[6] strains and compared 
them with those of global G12P[6] strains as well as G1P[8], G12P[8] and G2P[4] 
strains co-circulating during the clinical trial in Malawi.  
Materials and Methods 
The viruses 
A phase III efficacy trial of an attenuated human monovalent rotavirus vaccine, 
Rotarix® (GlaxoSmithKline Biologicals, Rixensart, Belgium), was conducted in 
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Blantyre, Malawi between 2007 and 2008 and stool samples were collected from both 
vaccine and placebo recipients (14). The major G and P genotypes identified in the 
RVA-positive specimens from the placebo recipients during the clinical trial were 
G12P[6] (27%), G8P[4] (24%) and G9P[8] (24%), with only 13% of strains being 
G1P[8] (14). In order to investigate possible reasons for the lower efficacy of the 
rotavirus vaccine in Malawi (49.4%) (14), molecular characterisation was carried out on 
21 strains selected from 88 RVA-positive specimens based on the amount of antigen 
(higher absorbance in ELISA), RNA migration patterns (absence of extra bands), and 
the quantity of the specimens (19). Among the 88 samples there were 25 G12P[6] 
strains; 11 showed identifiable RNA electropherotypes of which three were of long 
RNA pattern and eight were of short RNA pattern. Out of the 21 strains selected for 
molecular characterisation, there were four G12P[6] strains (MAL12, MAL39, MAL40, 
and MAL88). Among these, MAL12 and MAL40 represented long RNA strains 
whereas MAL39 and MAL88 represented short RNA strains. A single G2P[4] strain 
(MAL66) present among the 21 strains used in the previous study (19) was included in 
this whole genome analysis for comparison. Similarly, as representatives of strains with 
the Wa-like genetic background, one of three G1P[8] strains (MAL38) and the sole 
G12P[8] strain (MAL65) were selected for whole genome analysis.  
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RT-PCR and nucleotide sequencing 
Genomic RNAs were extracted from the infected culture fluid by using the 
QIAamp Viral RNA Mini Kit (QIAGEN Sciences, Germantown, MD, USA) according 
to the manufacturer’s instructions. An 8µl portion of genomic RNA was mixed with 
random primers (Invitrogen, Carlsbad, CA, USA) and dNTPs in a total volume of 9.5 µl 
and denatured at 97oC for 5 min. Reverse-transcription mixture (Invitrogen Super Script 
RNAse Reverse Transcriptase) was added to make the final reaction volume 20 µl. The 
thermal profile included incubation at 25oC for 5 min, 42oC for 60 min for reverse 
transcription and 70oC for 15 min to terminate the reaction.  
From the reverse-transcription products (cDNA), the VP4, VP1, VP2, VP3, NSP1, 
NSP2, NSP3 and NSP5 genes of MAL12, MAL39, MAL40 and MAL88 as well as the 
VP7, VP6 and NSP4 genes of MAL39 and MAL40 were amplified by PCR with 
primers specific to both ends of the relevant genome segment (20, 21) by using the 
GoTaq® Green Master Mix system (Promega Corporation, Madison, WI, USA) at 95oC 
for 5 min, and 35 cycles of amplification (at 94oC for 45 sec; at 45oC for 45 sec and at 
72oC for 2 to 6 min) followed by final extension at 72oC for 7 min. The amplified 
products were purified using an ExoSAP-IT purification kit (USB Products, Affymetrix, 
Cleveland, Ohio USA) according to the manufacturer’s instructions. Nucleotide 
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sequencing reactions were performed by fluorescent dideoxy chain termination 
chemistry using the BigDye Terminator Cycle Sequencing Ready Reaction Kit, version 
3.1 (Applied Biosystems, Foster City, CA, USA), and nucleotide sequences were 
determined using an ABI Prism 3730 Genetic Analyzer (Applied Biosystems).   
Sequence analyses 
Nucleotide sequences were aligned using the Megalign program in the Lasergene 
11 software package (DNAstar, Inc. Madison, WI, USA). The genotype of each genome 
segment was classified by using the RotaC2.0 automated genotyping tool for RVA (22). 
Calculation of nucleotide sequence identity and phylogenetic analysis were performed 
by using MEGA ver. 6.06 (23). Multiple sequence alignment was carried out using the 
MUSCLE program, and the genetic distances between sequences were calculated by the 
p-distance method. Maximum likelihood phylogenetic trees were constructed using the 
best-fit nucleotide substitution model based on the Bayesian Information Criterion score, 
i.e. Tamura 3-parameter model with gamma rate distribution (T92+G), for the VP7, 
VP4 and VP3 genes using MEGA ver.6.06. The statistical significance at each node was 
calculated with 1000 pseudo-replicate trials.  
The Bayesian Markov chain Monte Carlo (MCMC) framework implemented in 
BEAST ver.1.8.1 (24) was employed to determine the time of the most recent common 
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ancestor (tMRCA) and the divergence time. The nucleotide sequence dataset for each 
analysis comprised dated sequences of globally circulating strains similar to the VP7 
(n=256), VP4 (n=53), VP6 (n=94) and VP3 (n=108) genes of the Malawian G12P[6] 
strains. Using the best-fit model - Tamura Nei with a gamma distributed rate variation 
among sites (TN93+G), an uncorrelated lognormal relaxed clock model (25) and a 
coalescent constant size tree prior (26), two independent analyses were carried out for 
100 million, 20 million, 40 million and 25 million generations for the VP7, VP4, VP6 
and VP3 genes, respectively. Log files were examined using the Tracer software ver.1.6 
(http://tree.bio.ed.ac.uk/software/tracer/) to ensure that each analysis had reached 
convergence and effective sampling sizes were >200. Maximum clade credibility trees 
were annotated using the TreeAnnotator and viewed with FigTree ver.1.42 
(http://tree.bio.ed.ac.uk/software/figtree/). 
Nucleotide sequence accession numbers 
The nucleotide sequences for the VP1, VP2, VP3, VP4, VP6, VP7, NSP1, NSP2, 
NSP3, NSP4, and NSP5 genes of MAL38, MAL39, MAL40, MAL65 and MAL66, the 
VP1, VP2, VP3, VP4, NSP1, NSP2, NSP3, and NSP5 genes of MAL12 and MAL88 
were deposited in GenBank/DDBJ under accession numbers from AB938240 to 
AB938310. The VP7, VP6, and NSP4 genes of MAL12 and those of MAL88 were used 
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from the preceding study (19). The accession numbers of MAL12 are JN59143 (VP7), 
JN591408 (VP6) and JN591393 (NSP4), and those of MAL88 are JN591407 (VP7), 
JN591412 (VP6), and JN591397 (NSP4). As only partial VP4 genes of MAL12 and 
MAL88 were determined in the preceding study (19), the near-full lengths of these 
genes were newly determined and deposited under new accession numbers AB938245 
and AB938248, respectively. 
Results 
Genotype constellation of Malawian G12P[6] strains 
We determined the nucleotide sequences of the VP4, VP1, VP2, VP3, NSP1, 
NSP2, NSP3 and NSP5 genes of MAL12, MAL39, MAL40 and MAL88 as well as the 
VP7, VP6 and NSP4 genes of MAL39 and MAL40. When taken together with the 
sequence information obtained in the previous study (19), the full genotype 
constellation of MAL12 and MAL40 was G12-P[6]-I1-R1-C1-M1-A1-N1-T1-E1-H1 
and that of MAL39 and MAL88 was G12-P[6]-I2-R2-C2-M1-A2-N2-T2-E2-H2 (Table 
1). We also sequenced all genome segments of MAL38, MAL65 and MAL66, and 
determined their genotype constellation as G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, 
G12-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, and 
G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2, respectively (Table 1).  
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While the long RNA pattern strains, MAL12 and MAL40, had a Wa-like 
genotype constellation, the short RNA pattern strains, MAL39 and MAL88, had a 
DS-1-like genotype constellation except for their VP3 gene (M1); thus, MAL39 and 
MAL88 were a mono-reassortant in which the VP3 gene was reassorted from a strain 
possessing the Wa-like genotype constellation. The 
G12-P[6]-I1-R1-C1-M1-A1-N1-T1-E1-H1 genotype constellation of MAL12 and 
MAL40 is shared by many global G12P[6] strains such as the ones detected in 
Bangladesh (Dhaka12-03) (27), the United States of America (US6597) (28), South 
Korea (CAU195, CAU214) (29), Germany (GER172-08) (30), Cameroon (ES283) (31) 
and South Africa (3176WC) (32) (Table 1). An exception was Matlab 13-03, another 
Bangladeshi strain (27) that had T2 as its NSP3 genotype. By contrast, the 
G12-P[6]-I2-R2-C2-M1-A2-N2-T2-E2-H2 constellation of MAL39 and MAL88 was 
unique, and the only other G12P[6] strains possessing the DS-1-like backbone reported 
to date were three Bangladeshi G12P[6] strains each of which possess a unique 
genotype constellation (Table 1). However, none of them possess an M1VP3 gene.  
Phylogenetic relationships at the lineage level and Bayesian analysis 
Relationship within the G12P[6] strains possessing the same genotype constellation 
The two strains possessing the Wa-like genotype constellation (MAL12 and 
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MAL40) shared high nucleotide sequence identities of 99.7 to 100% across the 11 genes. 
Similarly, the two strains possessing the DS-1-like genotype constellation (MAL39 and 
MAL88) shared high nucleotide sequence identities of 99.6 to 100% across the 11 genes. 
Thus, MAL12 and MAL40 were virtually indistinguishable from each other as were 
MAL39 and MAL88. 
VP7 genes 
When a phylogenetic tree was drawn for the G12 VP7 genes, the four G12P[6] 
strains (MAL39, MAL88, MAL12 and MAL40) and one G12P[8] strain (MAL65) 
belonged to a well-established lineage III as did many global G12 strains (Fig. 1A). The 
sequences of the VP7 gene of the Malawian G12 strains were very similar to each other 
(99.4 to 99.9%) as well as to that of some African G12P[6] strains such as those of 
Kenyan strains KDH633 and KDH684 (99.7 to 99.8% identical with MAL39/MAL88) 
(Table 2A). Thus, the G12 VP7 gene of the Malawian and Kenyan G12P[6] strains were 
considered to share an immediate and direct ancestor. Bayesian MCMC analysis 
estimated the tMRCA of the cluster containing the VP7 gene of all the five Malawian 
and the two Kenyan G12 strains together with nearby G12 strains from Asia and South 
Africa to be 2002 (Fig. 2A).   
VP4 genes 
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When a phylogenetic tree was drawn for the VP4 genes of Malawian G12P[6] 
strains together with representative P[6] strains, the VP4 genes of MAL12 and MAL40 
(Wa-like constellation) were under the same cluster together with those of the G8P[6] 
strains that predominantly circulated in Malawi between 2003 and 2005 (33) (shaded in 
grey near the bottom of Fig. 1B) with the OP2-668 strain possessing the highest 
nucleotide sequence identity (99.2%) to MAL12 (Table 3). On the other hand, the VP4 
genes of MAL39 and MAL88 (a VP3 gene mono-reassortant with the DS-1-like 
backbone) clustered together with the VP4 genes of G1P[6], G9P[6] and G12P[6] 
strains detected in Africa (Kenya, Zambia, South Africa, etc.) (contained in the triangle 
highlighted in grey at the top of Fig. 1B), and the cluster was located far from the one 
containing MAL12 and MAL40 (shaded in grey near the bottom of Fig. 1B). The 
nucleotide sequence identity between MAL12 and MAL40, and that between MAL39 
and MAL88 were high (99.7% and 99.8%, respectively), whereas the nucleotide 
sequence identities between MAL12/MAL40 and MAL39/MAL88 were much lower 
(97.9%) (Table 3). When the phylogenetic relationships and the nucleotide sequence 
identities were taken together, Malawian G12P[6] strains with two distinct genetic 
backgrounds did not appear to share an immediate ancestor regarding the P[6] VP4 gene. 
Bayesian MCMC analysis estimated the time of divergence of the cluster containing 
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MAL12 and MAL40 from the cluster containing MAL39 and MAL88 to be 1996 
(indicated by an arrow in Fig. 2B).    
VP3 genes 
The VP3 genes of the four G12P[6] (MAL12/MAL40 and MAL39/MAL88), one 
G1P[8] (MAL38) and one G12P[8] (MAL65) strains had the same M1 genotype (Table 
1). The nucleotide sequence identity of MAL39 and MAL88 were 100%, and the 
nucleotide sequence identities between any pair of MAL12, MAL40, MAL38 and 
MAL65 were 99.2 to 99.7% (Table 3). By contrast, the nucleotide sequence identity of 
any pair between the former (the MAL39/MAL88 pair) and latter strains (MAL12, 
MAL40, MAL38 and MAL65) were much lower (98.3 to 98.5%) (Table 3); the cluster 
containing MAL39 and MAL88 was distinct from the cluster containing MAL12, 
MAL40, MAL38 and MAL65 (indicated by the clusters shaded in grey near the top and 
bottom of Fig. 1C). Bayesian MCMC analysis estimated the time of divergence of the 
cluster containing MAL39 and MAL88 from the one containing MAL12, MAL40, 
MAL38, and MAL65 to be 1999 (indicated by an arrow in Fig.2C). When a BLAST 
search was carried out with the MAL39 VP3 sequence as the query sequence, many 
VP3 genes for African G12P[6] strains had VP3 genes that were 99.2 to 99.7% identical 
with MAL39/MAL88 (Table 2A), and they clustered together with MAL39/MAL88 
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(shaded in grey near the top of Fig.1C).  
The backbone genes of the DS-1-like G12P[6] strains 
When BLAST searches were repeated with the MAL39 sequences as the query 
sequence, a few G2P[4] strains such as CU209-KK/08 detected in Thailand as well as 
VU05-06-45 and VU08-09-11 detected in the United States of America were found to 
possess the cognate genes that were >99.2% identical to MAL39 except the NSP3 
identity between MAL39 and CU209-KK (98.5%) (Table 2B). A locally co-circulating 
G2P[4] strain (MAL66), however, showed much lower sequence identities in any of the 
VP1, VP2, VP6, and non-structural protein genes that shared the same genotypes (92.9 
to 98.6%) (Table 2B); hence MAL66 was unlikely to share the backbone genes with the 
DS-1-like G12P[6] strains. Bayesian MCMC analysis estimated that even the VP6 
genes that showed the highest sequence identity (98.6%) among the 11 genes of 
MAL88 and MAL66 diverged in 1994 (data not shown). 
The backbone genes of the Wa-like G12P[6] strains 
To understand the origin of the internal capsid (VP1, VP2, VP3, and VP6) and 
non-structural protein (NSP1, NSP2, NSP3, NSP4, and NSP5) genes of the G12P[6] 
strains possessing the Wa-like genetic backbone, the BLAST search was performed 
using each gene of the MAL40 as the query sequence and identified the strains that had 
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the closest sequences. In all of these genes there were African strains that were >99.2% 
identical to MAL12 (Table 3). No single strain showed the highest sequence identity to 
MAL12 in all the genes; DPRU309 (G12P[8]) and DPRU1417 (G9P[8]) showed the 
highest identities in six genes shown in Table 3. When each of such sequences was 
included in the phylogenetic tree of the respective genome segment, they clustered 
together with MAL12 and MAL40 (data not shown). Taken together, these observations 
suggest that the Wa-like G12P[6] strains shared their backbone genes with Wa-like 
strains commonly circulating in Africa. 
When the internal capsid (VP1, VP2, VP3, and VP6) and non-structural protein 
(NSP1, NSP2, NSP3, NSP4, and NSP5) genes of the MAL12/MAL40 pair were 
compared with the cognate genes of the contemporary Malawian strains possessing the 
same genotypes, i.e., MAL38 (G1P[8]) and MAL65 (G12P[8]), the MAL12/MAL40 
pair and MAL65 shared high nucleotide sequence identities (99.1 to 99.7%) (Table 3) 
and clustered together in the phylogenetic trees except the NSP4 and NSP5 genes (data 
not shown). On the other hand, the MAL12/MAL40 pair and MAL38 shared high 
nucleotide sequence identities (99.2 to 99.7%) and clustered together only in the VP1, 
VP2, VP3, and NSP1 genes (data not shown).  
Discussion 
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The confirmation and extension of the hypothesis postulated in the preceding study 
This study determined the full genotype constellations of four Malawian G12P[6] 
strains, and identified two pairs each of which had a distinct genotype constellation; one 
pair possessing long RNA patterns (MAL12 and MAL40) had a complete Wa-like 
genotype constellation (I1-R1-C1-M1-A1-N1-T1-E1- H1), whereas the other pair 
possessing short RNA patterns (MAL39 and MAL88) were a single VP3 gene 
substitution reassortant on the background of the DS-1-like genotype constellation 
(I2-R2-C2-M1-A2-N2-T2-E2-H2). Thus, the three hybrid bands that were previously 
shown to appear around the regions of genome segments 2/3, 4, and 7/8/9 across the 
four G12P[6] strains (19) were determined to be the VP3, the VP4, and the VP7 gene, 
respectively. However, the hypothesis that the DS-1-like G12P[6] strains (MAL39 and 
MAL88) were generated by a locally-occurring reassortment event between the Wa-like 
G12P[6] strains (MAL12 and MAL40) and G2P[4] strains (such as MAL66) required 
revision. Whole genome sequencing of the four G12P[6] strains together with three 
locally co-circulating G2P[4], G1P[8] and G12P[8] strains followed by phylogenetic 
and Bayesian MCMC analyses provided an accurate and more precise understanding of 
how these G12P[6] strains with two different genetic backgrounds emerged in Malawi. 
The evolutionary pathway through which the DS-1-like G12P[6] strains likely 
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emerged in Malawi. 
While the two pairs of the G12P[6] strains shared the same genotype in the VP3, 
the VP4, and the VP7 gene, only the VP7 genes showed a high degree (99.4 to 99.6%) 
of nucleotide sequence identity and were considered to share a recent common ancestor. 
Nevertheless, Bayesian MCMC analysis of the VP7 genes estimated that the tMRCA of 
the DS-1-like G12P[6] pair (MAL39 and MAL88) and Kenyan G12P[6] strains was 
more recent (2006) than the tMRCA of the DS-1-like pairs and Wa-like pairs (2002). 
Furthermore, the fact that all of the VP7, VP4 and VP3 genes of the MAL39/MAL88 
pair shared the nearly the same tMRCA (between 2005 and 2006) with African Wa-like 
G12P[6] strains but not with Malawian Wa-like G12P[6] strains suggests the occurrence 
of a single reassortment event in which an African Wa-like G12P[6] strain donated the 
three genes namely the VP7, VP4 and VP3 genes to a strain possessing the DS-1-like 
genetic backbone. The time point of the reassortment (between 2005 and 2006) was 
immediately before the year of detection of the DS-1-like G12P[6] strains in Malawi 
(2007). The observation that four Wa-like strains (MAL12, MAL40, MAL65, and 
MAL38) co-circulating with MAL39/MAL88 did not share high sequence identities in 
the VP3 and the VP4 genes lent support to the hypothesis that the ressortment event 
likely occurred outside Malawi.  
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Similarly, the source of the DS-1-like strain that provided the remaining eight 
genes to MAL39/MAL88 was unlikely in Malawi as a co-circulating G2P[4] strain 
(MAL66) did not show high sequence identities. Instead, the source likely existed 
among globally circulating G2P[4] strains since high nucleotide sequence identities 
(99.2 to 99.9%) of the eight genes (VP1, VP2, VP6, NSP1, NSP2, NSP3, NSP4, and 
NSP5) were observed between the Malawian DS-1-like G12P[6] pair (MAL39/MAL88) 
and G2P[4] strains detected in either Thailand (CU209-KK) or the United States of 
America (VU05-06-45). Thus, we hypothesised that the DS-1-like G12P[6] strains were 
generated around 2006 by reassortment between a Wa-like G12P[6] strain elsewhere in 
Africa and a globally-circulating G2P[4] strain.  
The evolutionary pathway through which the Wa-like G12P[6] strains likely emerged 
in Malawi. 
The Wa-like G12P[6] strains (MAL12 and MAL40) shared high sequence 
identities (>99%) in eight genes (VP1, VP2, VP3, VP6, VP7, NSP1, NSP2, and NSP3) 
with a co-circulating Malawian G12P[8] strain (MAL65), and the NSP4 and NSP5 
genes with a South African G12P[8] strain (DPRU123). The remaining VP4 gene was 
99.2% identical with a Malawian G8P[6] strain (OP2-688). Furthermore, many African 
strains possessing G1, G9 and G12 showed high sequence identities (>99%) in any one 
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of the genes carried by the MAL12/MAL40 pair. This suggests that MAL12 and 
MAL40 were one of those Wa-like G12P[6] strains commonly circulating in Africa. 
The observation that no single strain showed a high level of sequence identities with 
MAL12 and MAL40 across the 11 genes was taken as evidence for the frequent 
occurrence of genetic reassortment after the introduction of G12 strains in Africa.   
Interpretation of diverse lineage constellations of African G12P[6] strains  
Despite a presumed short history of circulation of G12 strains in Africa, there was 
a degree of genomic diversity at the level of lineage of the internal capsid and 
non-structural protein genes of the strains that carried the G12 VP7 gene. Even the two 
pairs of G12P[6] strains detected in a single year in the same place lacked high 
sequence identities enough to be considered to derive from a recent and direct ancestor 
except for the VP7 gene. This suggests frequent occurrence of reassortment events 
among co-circulating G12 strains in Africa. In Africa, the source of DS-1-like internal 
capsid and non-structural protein genes is not limited to G2P[4] strains but there is 
abundance of P[6] strains with the DS-1-like backbone. Thus, there is ample 
opportunities for G12 strains to reassort and acquire DS-1-like genetic backbone.  
Culture-adaptation of RVA strains from clinical specimens 
A caveat may be necessary as the RVA strains used in this study as well as in the 
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preceding study (19) were all adapted in cell culture. While culture-adaption allows 
virtually unlimited amount of materials for analysis (the amount of the original faecal 
suspensions was limited), selection of variants may occur from the quasispecies 
population present in the original host. There are a few studies relevant to this point. 
After 33 passages in cell culture, one non-synonymous substitution (0.2%) was reported 
to occur in the NSP4 gene of strain 89-12 (a precursor to the Rotarix vaccine strain) 
(34). In another study in which a porcine rotavirus strain with partially-duplicated NSP5 
gene was passaged by serial plaque-to-plaque transfer, Blackhall, et al (35) observed 
that plaque-to-plaque transfer resulted in selection of variants of reduced fitness with 
occasional nucleotide substitutions. Such fitness changes resulting from repeated 
bottlenecking effects were not observed when viruses were passaged in cell culture by 
the standard moderate dilutions. They reported overall mutation rate (of the NSP5 gene) 
was a maximum value of 5 x 10-5 per nucleotide per replication (35). Under rather 
complicated alternating experimental conditions in vivo and in cell culture, a slightly 
more frequent (0.4-1.7%) mutations were noted in the murine RVA system (36). While 
the number of passages (up to 5 times) during culture adaptation in this study was far 
fewer than the above examples, caution in interpretation is warranted. Caution also 
needs to be exercised when the host is infected with more than one RVA strain as 
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reassortment may occur during the cell-culture adaptation (37). However, neither 
polyacrylamide gel electrophoresis nor RT-PCR genotyping suggested the presence of 
an extra strain in the faecal samples used in this study.    
Conclusions 
This study was intended to confirm the prediction by RNA-RNA hybridisation 
studies of what had appeared to be an uncomplicated reassortment event occurring 
between locally co-circulating, Wa-like and DS-1-like G12P[6] strains. However, this 
study uncovered the evolutionary pathways through which two distinct G12P[6] strains 
emerged in Malawi at the precision level that could be achieved by whole genome 
sequencing and Bayesian phylogenetics. Co-circulation of Wa-like and DS-1-like G12 
strains let alone the predominance of DS-1-like G12 strains over the Wa-like has so far 
been observed rarely. Further investigation will be required to see whether the 
DS-1-like G12 strains will continue to spread efficiently among children in Malawi and 
elsewhere. 
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Figure Legends 
Fig. 1 - Phylogenetic trees for the G12 VP7 (A), P[6] VP4 (B) and M1 VP3 (C) genes 
of Malawian G12P[6] strains sequenced in this study and in the preceding study 
(Nakagomi et al., 2012) and genes bearing the respective genotypes of global RVA 
strains for which the full genome sequence information is available in the GenBank 
database. The trees were constructed using the Maximum Likelihood method using 
MEGA 6.06 software package. Significant bootstrap values >70 obtained after 1000 
bootstrap replicates are shown at each node. The G12P[6] strains sequenced in this 
study which possess the DS-1-like genetic backbone are indicated with filled red 
circles whereas those with the Wa-like genetic backbone are indicated with filled 
green circles. For simplicity, large clusters are collapsed into triangles. The scale bar 
at the bottom of each tree indicates the genetic distance expressed as nucleotide 
substitutions per site 
 
Fig. 2 - Simplified maximum clade credibility trees of dated G12 VP7, P[6] VP4 and 
M1 VP3 genes of Malawian G12P[6] strains sequenced in this study and in the 
preceding study (Nakagomi et al., 2012) and genes bearing the respective genotypes 
36 
 
of global RVA strains for which the full genome sequence information is available in 
the GenBank database. Trees were constructed using the Bayesian Markov chain 
Monte Carlo method implemented in BEAST v.1.8.1 software package. The years of 
divergence and the time of the most recent common ancestor together with the 95% 
Highest Posterior Density intervals of clusters or lineages of interest are shown at the 
nodes. The G12P[6] strains sequenced in this study which possess the DS-1-like 
genetic backbone are indicated with filled red circles whereas those with the Wa-like 
genetic backbone are indicated with filled green circles. For simplicity, large clusters 
are collapsed into triangles. The in-lay Table shows the parameters used and obtained 
in the MCC analysis. The scale bar at the bottom of each MCC tree indicates time 
scale in years 
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Fig. 1A: VP7 ML tree
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Fig. 1B: VP4 ML tree
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Fig. 1C: VP3 ML treeG1P[8]/2003/India
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